Acadian Asset Management »

Sutro Biopharma shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9M 338k 11.56

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Bk Nova Cad (BNS)
JPMorgan Chase & Co. (JPM)
Toronto Dominion Bk Ont Com New (TD)
Deutsche Bank A G Namen Akt (DB)
Ubs Group SHS (UBS)
Broadcom Ord Shs (AVGO)
Booking Holdings (BKNG)
Citigroup Com New (C)
Telefonaktiebolaget Lm Erics Adr B Sek 10 (ERIC)

View all positions for Acadian Asset Management

Top funds holding Sutro Biopharma

Affinity Asset Advisors
Vanguard Group
Acadian Asset Management
Samsara BioCapital
Eversept Partners
Opaleye Management
Point72 Asset Management
Tang Capital Management
Renaissance Technologies
GSA Capital Partners
Marshall Wace
Geode Capital Management
Longwood Capital Partners
ADAR1 Capital Management
Fisher Investments

View all funds holding Sutro Biopharma